PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK)
IDR 2260.0
(-3.42%)
IDR 2260.0
(-3.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1135.04 Billion IDR | 86.94% |
| 2022 | 607.18 Billion IDR | 317.96% |
| 2021 | 145.27 Billion IDR | -67.18% |
| 2020 | 442.64 Billion IDR | 2176.83% |
| 2019 | 19.44 Billion IDR | 121.7% |
| 2018 | -89.59 Billion IDR | 41.16% |
| 2017 | -152.26 Billion IDR | 70.83% |
| 2016 | -521.96 Billion IDR | -766.38% |
| 2015 | 78.32 Billion IDR | 857.6% |
| 2014 | -10.33 Billion IDR | -122.95% |
| 2013 | 45.05 Billion IDR | -90.96% |
| 2012 | 498.42 Billion IDR | 167.55% |
| 2011 | 186.28 Billion IDR | 31.41% |
| 2010 | 141.76 Billion IDR | 42.06% |
| 2009 | 99.79 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1304.34 Billion IDR | 8.76% |
| 2024 Q1 | 1203.88 Billion IDR | 6.06% |
| 2023 Q4 | 1135.04 Billion IDR | 4.32% |
| 2023 Q2 | 970.74 Billion IDR | 22.63% |
| 2023 Q1 | 791.59 Billion IDR | 30.37% |
| 2023 Q3 | 1088.07 Billion IDR | 12.09% |
| 2023 FY | 1135.04 Billion IDR | 86.94% |
| 2022 Q1 | 288.1 Billion IDR | 98.32% |
| 2022 Q2 | 379.5 Billion IDR | 31.73% |
| 2022 Q3 | 472.94 Billion IDR | 24.62% |
| 2022 Q4 | 607.18 Billion IDR | 28.38% |
| 2022 FY | 607.18 Billion IDR | 317.96% |
| 2021 Q1 | 539.06 Billion IDR | 21.78% |
| 2021 Q3 | 139.3 Billion IDR | -75.65% |
| 2021 FY | 145.27 Billion IDR | -67.18% |
| 2021 Q2 | 572.13 Billion IDR | 6.13% |
| 2021 Q4 | 145.27 Billion IDR | 4.28% |
| 2020 FY | 442.64 Billion IDR | 2176.83% |
| 2020 Q3 | 437.72 Billion IDR | 650.38% |
| 2020 Q1 | 57 Billion IDR | 193.24% |
| 2020 Q2 | 58.33 Billion IDR | 2.32% |
| 2020 Q4 | 442.64 Billion IDR | 1.12% |
| 2019 Q4 | 19.44 Billion IDR | 158.73% |
| 2019 FY | 19.44 Billion IDR | 121.7% |
| 2019 Q1 | -23.48 Billion IDR | 73.79% |
| 2019 Q2 | 7.83 Billion IDR | 133.37% |
| 2019 Q3 | -33.1 Billion IDR | -522.39% |
| 2018 Q2 | -45.54 Billion IDR | 66.21% |
| 2018 Q4 | -89.59 Billion IDR | -73.61% |
| 2018 FY | -89.59 Billion IDR | 41.16% |
| 2018 Q1 | -134.78 Billion IDR | 11.48% |
| 2018 Q3 | -51.6 Billion IDR | -13.32% |
| 2017 FY | -152.26 Billion IDR | 70.83% |
| 2017 Q1 | -492.37 Billion IDR | 5.67% |
| 2017 Q2 | -396.18 Billion IDR | 19.53% |
| 2017 Q3 | -284.77 Billion IDR | 28.12% |
| 2017 Q4 | -152.26 Billion IDR | 46.53% |
| 2016 Q1 | 88.19 Billion IDR | 12.59% |
| 2016 FY | -521.96 Billion IDR | -766.38% |
| 2016 Q2 | 94.83 Billion IDR | 7.53% |
| 2016 Q4 | -521.96 Billion IDR | -1028.14% |
| 2016 Q3 | 56.23 Billion IDR | -40.7% |
| 2015 FY | 78.32 Billion IDR | 857.6% |
| 2015 Q4 | 78.32 Billion IDR | 12.21% |
| 2015 Q3 | 69.8 Billion IDR | 120.26% |
| 2015 Q2 | 31.69 Billion IDR | 202.82% |
| 2015 Q1 | 10.46 Billion IDR | 201.22% |
| 2014 FY | -10.33 Billion IDR | -122.95% |
| 2014 Q4 | -10.33 Billion IDR | -110.95% |
| 2014 Q3 | 94.41 Billion IDR | -26.93% |
| 2014 Q2 | 129.21 Billion IDR | 48.67% |
| 2014 Q1 | 86.91 Billion IDR | 92.91% |
| 2013 Q1 | 524.39 Billion IDR | 5.21% |
| 2013 Q2 | 610.16 Billion IDR | 16.36% |
| 2013 FY | 45.05 Billion IDR | -90.96% |
| 2013 Q3 | 248.26 Billion IDR | -59.31% |
| 2013 Q4 | 45.05 Billion IDR | -81.85% |
| 2012 Q3 | 372.15 Billion IDR | 37.6% |
| 2012 Q4 | 498.42 Billion IDR | 33.93% |
| 2012 Q2 | 270.46 Billion IDR | 24.19% |
| 2012 Q1 | 217.78 Billion IDR | 16.9% |
| 2012 FY | 498.42 Billion IDR | 167.55% |
| 2011 Q4 | 186.28 Billion IDR | 0.0% |
| 2011 FY | 186.28 Billion IDR | 31.41% |
| 2010 FY | 141.76 Billion IDR | 42.06% |
| 2009 FY | 99.79 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Bundamedik Tbk | 497.89 Billion IDR | -127.969% |
| PT Metro Healthcare Indonesia Tbk | 427.86 Billion IDR | -165.28% |
| PT Medikaloka Hermina Tbk | 1405.68 Billion IDR | 19.253% |
| PT Mitra Keluarga Karyasehat Tbk | -839.7 Billion IDR | 235.173% |
| PT Murni Sadar Tbk | 490.08 Billion IDR | -131.604% |
| PT Famon Awal Bros Sedaya Tbk | 252.54 Billion IDR | -349.451% |
| PT Royal Prima Tbk | -26.49 Billion IDR | 4384.28% |
| PT Kedoya Adyaraya Tbk | -57.42 Billion IDR | 2076.618% |
| PT Sarana Meditama Metropolitan Tbk | 834.93 Billion IDR | -35.944% |
| PT Siloam International Hospitals Tbk | -552.3 Billion IDR | 305.512% |